LONDON (Reuters) - AstraZeneca Plc is seeking European approval to sell its drug Seroquel XR as a treatment for anxiety, the Anglo-Swedish group said on Tuesday. If approved, Seroquel XR would be the ...

A patient with breast cancer and a history of anxiety and other symptoms was managed with virtual reality device and pharmacotherapy to enable her to complete RT CT simulation.

An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an adjunctive treatment in adults with major depressive disorder (MDD) and insomnia ...